Clinical Trial

Fecal Calprotectin in Patients Infected with Intestinal Protozoan Infections

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 24, 2025 (before its estimated October 2025 completion). Its status may not reflect the trial's current state.
Summary
Calprotectin extracted from stool can be detected easily using ELISA. Numerous studies have shown that fecal calprotectin concentrations demonstrate a good correlation with intestinal inflammation This study aims to detect the relationship between fecal calprotectin and Blastocystis hominis and Entamoeba histolytica infections.
Trial Details
NCT Number NCT06890455
Lead Sponsor Sohag University
Conditions Fecal Calprotectin in Intestinal Protozoa
Enrollment 120 participants
Start Date 2025-03
Primary Completion 2025-10 (estimated)
Study Completion 2026-02 (estimated)
Updated on ClinicalTrials.gov 2025-03-24